The global targeted drug delivery system market is expected to grow at a CAGR of 8.5% during the forecast period, from 2021 to 2030. The market is driven by factors such as increasing prevalence of chronic diseases, rising demand for personalized medicine, and technological advancements in drug delivery systems.
Nano Tubes: The nano tubes segment accounted for the largest share in the global targeted drug delivery system market in 2018. Nano tubes are used for first order targeting (organ compartmentalization) and second order targeting (cellular targeting). They are also used as carriers for drugs that cannot be administered orally or intravenously due to their low solubility or stability in blood plasma. Nano tubes can be made from various materials such as polymers, metals, and ceramics; they can also be coated with polymers or other materials to improve their properties such as biocompatibility and bioavailability of drugs carried by them.
Nano Wires: The nano wires segment accounted for the second-largest share in the global targeted drug delivery system market in 2018. Nano wires are used primarily for third order targeting (intracellular targeting). They have a high surface area-to-volume ratio which enables them to carry large amounts of drugs into cells without being degraded by enzymes present inside cells; this helps increase intracellular concentrations of drugs delivered through these nanowires which leads to improved therapeutic efficacy against cancerous cells and other diseases like Alzheimer’s disease that require intracellular treatment with specific molecules like antibodies or small interfering RNA molecules (siRNA).
- The increasing prevalence of chronic diseases such as diabetes and cancer is driving the growth of the targeted drug delivery system market.
- The increasing demand for personalized medicine is also driving the growth of this market.
- The growing number of aging population in developed countries is also a factor that will drive the growth of this market in future years.
- Increasing government funding for research and development activities related to targeted drug delivery systems will also fuel the growth of this market in future years.
- Increasing awareness about benefits offered by these systems among patients, healthcare providers, and pharmaceutical companies will also drive the growth of this market.
Industry Growth Insights published a new data on “Targeted Drug Delivery System Market”. The research report is titled “Targeted Drug Delivery System Market research by Types (Nano Tubes, Nano Wires, Nano Shells, Quantum Dots, Nano Pros), By Applications (First Order Targeting (Organ Compartmentalization), Second Order Targeting (Cellular Targeting), Third Order Targeting (Intracellular Targeting)), By Players/Companies 3M Company, Abbott Laboratories, Ablynx NV, Aciont Inc, Acrux, Agilis Biotherapeutics LLC, Aileron Therapeutics Inc, Nano Precision Medical Inc, Novartis Pharmaceuticals Corp, Oxford Biomedica, PharmaIN Corp, PolyMicrospheres, Presage Biosciences Inc, Pulmatrix Inc, Quark Pharmaceuticals Inc, RegeneRx Biopharmaceuticals Inc, Replicor Inc, Rexahn Pharmaceuticals Inc, Roche Holding AG, Savara Inc, Serina Therapeutics Inc., Silenseed Ltd., SoluBest Ltd, Suda Ltd, Taiwan Liposome Co. Ltd., Pipeline, Vect-Horus S.A.S., Vectura Group plc, WAVE Life Sciences Pvt. Ltd., Xigen SA”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Targeted Drug Delivery System Market Research Report
By Type
Nano Tubes, Nano Wires, Nano Shells, Quantum Dots, Nano Pros
By Application
First Order Targeting (Organ Compartmentalization), Second Order Targeting (Cellular Targeting), Third Order Targeting (Intracellular Targeting)
By Companies
3M Company, Abbott Laboratories, Ablynx NV, Aciont Inc, Acrux, Agilis Biotherapeutics LLC, Aileron Therapeutics Inc, Nano Precision Medical Inc, Novartis Pharmaceuticals Corp, Oxford Biomedica, PharmaIN Corp, PolyMicrospheres, Presage Biosciences Inc, Pulmatrix Inc, Quark Pharmaceuticals Inc, RegeneRx Biopharmaceuticals Inc, Replicor Inc, Rexahn Pharmaceuticals Inc, Roche Holding AG, Savara Inc, Serina Therapeutics Inc., Silenseed Ltd., SoluBest Ltd, Suda Ltd, Taiwan Liposome Co. Ltd., Pipeline, Vect-Horus S.A.S., Vectura Group plc, WAVE Life Sciences Pvt. Ltd., Xigen SA
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
231
Number of Tables & Figures
162
Customization Available
Yes, the report can be customized as per your need.
Global Targeted Drug Delivery System Market Report Segments:
The global Targeted Drug Delivery System market is segmented on the basis of:
Types
Nano Tubes, Nano Wires, Nano Shells, Quantum Dots, Nano Pros
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
First Order Targeting (Organ Compartmentalization), Second Order Targeting (Cellular Targeting), Third Order Targeting (Intracellular Targeting)
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- 3M Company
- Abbott Laboratories
- Ablynx NV
- Aciont Inc
- Acrux
- Agilis Biotherapeutics LLC
- Aileron Therapeutics Inc
- Nano Precision Medical Inc
- Novartis Pharmaceuticals Corp
- Oxford Biomedica
- PharmaIN Corp
- PolyMicrospheres
- Presage Biosciences Inc
- Pulmatrix Inc
- Quark Pharmaceuticals Inc
- RegeneRx Biopharmaceuticals Inc
- Replicor Inc
- Rexahn Pharmaceuticals Inc
- Roche Holding AG
- Savara Inc
- Serina Therapeutics Inc.
- Silenseed Ltd.
- SoluBest Ltd
- Suda Ltd
- Taiwan Liposome Co. Ltd.
- Pipeline
- Vect-Horus S.A.S.
- Vectura Group plc
- WAVE Life Sciences Pvt. Ltd.
- Xigen SA
Highlights of The Targeted Drug Delivery System Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Nano Tubes
- Nano Wires
- Nano Shells
- Quantum Dots
- Nano Pros
- By Application:
- First Order Targeting (Organ Compartmentalization)
- Second Order Targeting (Cellular Targeting)
- Third Order Targeting (Intracellular Targeting)
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Targeted Drug Delivery System Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A targeted drug delivery system (TDS) is a medical device that uses nanotechnology to improve the ability of drugs to reach their target cells. TDSs can be used in a variety of treatments, including cancer, heart disease, and Alzheimer's disease.
Some of the major companies in the targeted drug delivery system market are 3M Company, Abbott Laboratories, Ablynx NV, Aciont Inc, Acrux, Agilis Biotherapeutics LLC, Aileron Therapeutics Inc, Nano Precision Medical Inc, Novartis Pharmaceuticals Corp, Oxford Biomedica, PharmaIN Corp, PolyMicrospheres, Presage Biosciences Inc, Pulmatrix Inc, Quark Pharmaceuticals Inc, RegeneRx Biopharmaceuticals Inc, Replicor Inc, Rexahn Pharmaceuticals Inc, Roche Holding AG, Savara Inc, Serina Therapeutics Inc., Silenseed Ltd., SoluBest Ltd, Suda Ltd, Taiwan Liposome Co. Ltd., Pipeline, Vect-Horus S.A.S., Vectura Group plc, WAVE Life Sciences Pvt. Ltd., Xigen SA.
The targeted drug delivery system market is expected to grow at a compound annual growth rate of 8.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Targeted Drug Delivery System Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Targeted Drug Delivery System Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Targeted Drug Delivery System Market - Supply Chain
4.5. Global Targeted Drug Delivery System Market Forecast
4.5.1. Targeted Drug Delivery System Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Targeted Drug Delivery System Market Size (000 Units) and Y-o-Y Growth
4.5.3. Targeted Drug Delivery System Market Absolute $ Opportunity
5. Global Targeted Drug Delivery System Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Targeted Drug Delivery System Market Size and Volume Forecast by Type
5.3.1. Nano Tubes
5.3.2. Nano Wires
5.3.3. Nano Shells
5.3.4. Quantum Dots
5.3.5. Nano Pros
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Targeted Drug Delivery System Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Targeted Drug Delivery System Market Size and Volume Forecast by Application
6.3.1. First Order Targeting (Organ Compartmentalization)
6.3.2. Second Order Targeting (Cellular Targeting)
6.3.3. Third Order Targeting (Intracellular Targeting)
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Targeted Drug Delivery System Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Targeted Drug Delivery System Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Targeted Drug Delivery System Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Targeted Drug Delivery System Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Targeted Drug Delivery System Demand Share Forecast, 2019-2026
9. North America Targeted Drug Delivery System Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Targeted Drug Delivery System Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Targeted Drug Delivery System Market Size and Volume Forecast by Application
9.4.1. First Order Targeting (Organ Compartmentalization)
9.4.2. Second Order Targeting (Cellular Targeting)
9.4.3. Third Order Targeting (Intracellular Targeting)
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Targeted Drug Delivery System Market Size and Volume Forecast by Type
9.7.1. Nano Tubes
9.7.2. Nano Wires
9.7.3. Nano Shells
9.7.4. Quantum Dots
9.7.5. Nano Pros
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Targeted Drug Delivery System Demand Share Forecast, 2019-2026
10. Latin America Targeted Drug Delivery System Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Targeted Drug Delivery System Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Targeted Drug Delivery System Market Size and Volume Forecast by Application
10.4.1. First Order Targeting (Organ Compartmentalization)
10.4.2. Second Order Targeting (Cellular Targeting)
10.4.3. Third Order Targeting (Intracellular Targeting)
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Targeted Drug Delivery System Market Size and Volume Forecast by Type
10.7.1. Nano Tubes
10.7.2. Nano Wires
10.7.3. Nano Shells
10.7.4. Quantum Dots
10.7.5. Nano Pros
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Targeted Drug Delivery System Demand Share Forecast, 2019-2026
11. Europe Targeted Drug Delivery System Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Targeted Drug Delivery System Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Targeted Drug Delivery System Market Size and Volume Forecast by Application
11.4.1. First Order Targeting (Organ Compartmentalization)
11.4.2. Second Order Targeting (Cellular Targeting)
11.4.3. Third Order Targeting (Intracellular Targeting)
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Targeted Drug Delivery System Market Size and Volume Forecast by Type
11.7.1. Nano Tubes
11.7.2. Nano Wires
1.7.3. Nano Shells
11.7.4. Quantum Dots
11.7.5. Nano Pros
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Targeted Drug Delivery System Demand Share, 2019-2026
12. Asia Pacific Targeted Drug Delivery System Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Targeted Drug Delivery System Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Targeted Drug Delivery System Market Size and Volume Forecast by Application
12.4.1. First Order Targeting (Organ Compartmentalization)
12.4.2. Second Order Targeting (Cellular Targeting)
12.4.3. Third Order Targeting (Intracellular Targeting)
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Targeted Drug Delivery System Market Size and Volume Forecast by Type
12.7.1. Nano Tubes
12.7.2. Nano Wires
12.7.3. Nano Shells
12.7.4. Quantum Dots
12.7.5. Nano Pros
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Targeted Drug Delivery System Demand Share, 2019-2026
13. Middle East & Africa Targeted Drug Delivery System Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Targeted Drug Delivery System Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Targeted Drug Delivery System Market Size and Volume Forecast by Application
13.4.1. First Order Targeting (Organ Compartmentalization)
13.4.2. Second Order Targeting (Cellular Targeting)
13.4.3. Third Order Targeting (Intracellular Targeting)
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Targeted Drug Delivery System Market Size and Volume Forecast by Type
13.7.1. Nano Tubes
13.7.2. Nano Wires
13.7.3. Nano Shells
13.7.4. Quantum Dots
13.7.5. Nano Pros
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Targeted Drug Delivery System Demand Share, 2019-2026
14. Competition Landscape
14.1. Global Targeted Drug Delivery System Market: Market Share Analysis
14.2. Targeted Drug Delivery System Distributors and Customers
14.3. Targeted Drug Delivery System Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. 3M Company
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Abbott Laboratories
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Ablynx NV
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Aciont Inc
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Acrux
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Agilis Biotherapeutics LLC
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Aileron Therapeutics Inc
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. Nano Precision Medical Inc
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Novartis Pharmaceuticals Corp
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Oxford Biomedica
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. PharmaIN Corp
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. PolyMicrospheres
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. Presage Biosciences Inc
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. Pulmatrix Inc
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. Quark Pharmaceuticals Inc
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. RegeneRx Biopharmaceuticals Inc
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. Replicor Inc
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. Rexahn Pharmaceuticals Inc
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. Roche Holding AG
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. Savara Inc
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
